Prostate laser vaporization is safe and effective in elderly men

Area of Science:

• Urology
• Geriatric Medicine
• Surgical Technology

Background:

• Limited data exist on laser photoselective vaporization (LVP) safety and efficacy in elderly men.
• Benign prostatic hyperplasia (BPH) significantly impacts quality of life in older populations.

Purpose of the Study:

• To compare the safety and efficacy of LVP for symptomatic BPH in men aged 75 years and older (elderly) versus those younger than 75 years.
• To evaluate perioperative outcomes and postoperative symptom improvement in these distinct age groups.

Main Methods:

• A retrospective study comparing 49 elderly men (≥75 years) with 153 younger men (<75 years) undergoing LVP for BPH between 2005 and 2012.
• Analysis included demographics, perioperative outcomes, complications, and changes in International Prostate Symptom Score (I-PSS) and urinary bother.

Main Results:

• Elderly men had higher rates of heart disease, gross hematuria, urinary retention, and anticoagulant use preoperatively.
• While elderly men had a longer hospital stay, there were no significant differences in transfusion rates or severe complications (Clavien III) between groups.
• One month post-surgery, elderly patients showed smaller improvements in I-PSS and urinary bother, but these differences resolved by 9 months follow-up.

Conclusions:

• Elderly men undergoing LVP for BPH exhibit comparable perioperative safety and short-term efficacy to younger counterparts.
• Despite increased preoperative comorbidities, LVP is a viable treatment option for symptomatic BPH in the elderly population.